Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Hironori Yoshii"'
Autor:
Tetsuo Nakayama, Takuji Kumagai, Yasuyo Kashiwagi, Hironori Yoshii, Kenta Honjo, Ritsuko Kubota-Koketsu, Yoshinobu Okuno, Shigeru Suga
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 14, Iss 12, Pp 2990-2998 (2018)
A clinical trial of a quadrivalent split influenza vaccine was performed in the 2014/15 season. Sixty-four subjects aged 6 months to 18 years were enrolled in order to investigate the relationship between cellular and humoral immune responses. Subjec
Externí odkaz:
https://doaj.org/article/9edbbf18a12748aaac58ee23b8dcaae4
Autor:
Ritsuko Kubota-Koketsu, Tetsuo Nakayama, Shigeru Suga, Yasuyo Kashiwagi, Hironori Yoshii, Kenta Honjo, Yoshinobu Okuno, Takuji Kumagai
Publikováno v:
Human Vaccines & Immunotherapeutics. 14:2990-2998
A clinical trial of a quadrivalent split influenza vaccine was performed in the 2014/15 season. Sixty-four subjects aged 6 months to 18 years were enrolled in order to investigate the relationship between cellular and humoral immune responses. Subjec
Autor:
Yasuyuki Gomi, Ryuichi Iwakiri, Koji Yamamoto, Megumi Hara, Shimpei Shirai, Ryo Shimoda, Hironori Yoshii, Yasuhisa Sakata, Nanae Tsuruoka, Kazuma Fujimoto
Publikováno v:
Inflammatory Bowel Diseases
Background and Aims No reports have described the immunogenicity and boosting effect of the quadrivalent inactivated influenza vaccine (QIV) in adults with inflammatory bowel disease. Methods Adults with Crohn’s disease or ulcerative colitis were r
Serostatus following live attenuated vaccination administered before pediatric liver transplantation
Autor:
Akihiko Saitoh, Kensuke Shoji, Isao Miyairi, Ippei Miyata, Mureo Kasahara, Hironori Yoshii, Seisuke Sakamoto, Takanori Funaki
Publikováno v:
Liver Transplantation. 21:774-783
After liver transplantation (LT), live attenuated vaccines (LAVs) are generally contraindicated. LAVs are recommended before LT for patients ≥ 6 months of age. However, the evidence supporting this practice is limited. Patients were enrolled before
Autor:
Shimpei Shirai, Megumi Hara, Yasuhisa Sakata, Nanae Tsuruoka, Koji Yamamoto, Ryo Shimoda, Yasuyuki Gomi, Hironori Yoshii, Kazuma Fujimoto, Ryuichi Iwakiri
Publikováno v:
Inflammatory Bowel Diseases; May2018, Vol. 24 Issue 5, p1082-1091, 10p
Autor:
Naoko Nishimura, Kensei Gotoh, Takao Ozakiv, Hironori Yoshii, Yoshinobu Okuno, Keiji Funahashi
Publikováno v:
Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases. 90(3)
In October 2014, the varicella vaccination policy in Japan was changed from a single voluntary inoculation to two routine inoculations. This paper reports the results of booster vaccination in children who did not show seroconversion after initial va
Autor:
Masaaki Matsuura, Asato Kojima, Mitsuru Akashi, Michiaki Takahashi, Toyokazu Ishikawa, Takami Akagi, Shigefumi Okamoto, Hironori Yoshii, Koichi Yamanishi, Yasuko Mori
Publikováno v:
Clinical and Vaccine Immunology. 19:17-22
To maintain immunity against Japanese encephalitis virus (JEV), a formalin-inactivated Japanese encephalitis (JE) vaccine should be administered several times. The repeated vaccination is not helpful in the case of a sudden outbreak of JEV or when ur
Publikováno v:
Virology. 377:289-295
Varicella-zoster virus (VZV) encodes five genes that do not have herpes simplex virus homologs. One of these genes, VZV open reading frame 1 (ORF1), encodes a membrane protein with a hydrophobic domain at its C-terminus that is predicted to be the tr
Autor:
Yasuko Mori, Pranee Somboonthum, Kazuhiro Nagaike, Takayoshi Imazawa, Hironori Yoshii, Koichi Yamanishi, Yoshiaki Yamagishi, Keiichi Ozono, Tomohiko Sadaoka
Publikováno v:
Journal of Virology. 82:795-804
Although envelope glycoprotein M (gM) is highly conserved among herpesviruses, the varicella-zoster virus (VZV) gM homolog has never been investigated. Here we characterized the VZV gM homolog and analyzed its function in VZV-infected cells. The VZV
Autor:
Takami Akagi, Yasuko Mori, Shigefumi Okamoto, Michiaki Takahashi, Toyokazu Ishikawa, Koichi Yamanishi, Mitsuru Akashi, Hironori Yoshii
Publikováno v:
Vaccine. 26:589-594
Japanese encephalitis (JE) is a serious disease caused by the JE virus (JEV), and vaccination is the only way to prevent the diseases. In Japan, the only JE vaccine currently available is an inactivated vaccine that requires multiple doses for effect